Wedbush Raises Price Target on IDEAYA Biosciences to $56 From $52, Maintains Outperform Rating
Wedbush Raises Price Target on IDEAYA Biosciences to $56 From $52, Maintains Outperform Rating
Wedbush将IDEAYA生物科学的目标价格从52美元上调至56美元,维持其超额表现评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册